Cargando…
Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785233/ https://www.ncbi.nlm.nih.gov/pubmed/36558202 http://dx.doi.org/10.3390/molecules27248730 |
_version_ | 1784857999188164608 |
---|---|
author | Godugu, Kavitha El-Far, Ali H. Al Jaouni, Soad Mousa, Shaker A. |
author_facet | Godugu, Kavitha El-Far, Ali H. Al Jaouni, Soad Mousa, Shaker A. |
author_sort | Godugu, Kavitha |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9785233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97852332022-12-24 Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 Godugu, Kavitha El-Far, Ali H. Al Jaouni, Soad Mousa, Shaker A. Molecules Correction MDPI 2022-12-09 /pmc/articles/PMC9785233/ /pubmed/36558202 http://dx.doi.org/10.3390/molecules27248730 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Godugu, Kavitha El-Far, Ali H. Al Jaouni, Soad Mousa, Shaker A. Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title | Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title_full | Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title_fullStr | Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title_full_unstemmed | Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title_short | Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 |
title_sort | correction: godugu et al. nanoformulated ajwa (phoenix dactylifera) bioactive compounds improve the safety of doxorubicin without compromising its anticancer efficacy in breast cancer. molecules 2020, 25, 2597 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785233/ https://www.ncbi.nlm.nih.gov/pubmed/36558202 http://dx.doi.org/10.3390/molecules27248730 |
work_keys_str_mv | AT godugukavitha correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597 AT elfaralih correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597 AT aljaounisoad correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597 AT mousashakera correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597 |